Anti-epileptogenic and anticonvulsant activity of L-2-amino-4-phosphonobutyrate, a presynaptic glutamate receptor agonist

Brain Research
A S Abdul-GhaniD E Jane

Abstract

The protective effect of amygdaloid (focally administered) doses of the presynaptic metabotropic glutamate receptor agonist, L-2-amino-4-phosphonobutyrate (L-AP4) was tested on the development of electrical kindling and in fully kindled animals. L-AP4 inhibited epileptogenesis at 10 nmol in 0.5 microl buffer, by preventing the increase in both seizure score and afterdischarge duration. The effects were reversible after withdrawal of the drug, with all treated animals subsequently progressing to the fully kindled state at the same rate as control animals. The same concentration of the drug was also effective when injected into fully kindled animals. It significantly decreased the mean seizure score by 88% (P < 0.005) and increased the mean generalized seizure threshold (GST) by 85% (P < 0.005). The increase in GST was accompanied by a significant delay before the onset of generalized seizure and by a 37% reduction in generalized seizure duration. MPPG ((RS)-alpha-methyl-4-phosphonophenyl glycine) a selective antagonist of L-AP4 at glutamate pre-synaptic receptors inhibited the depressant effect of L-AP4 in a dose-dependent manner. MPPG (10 nmol) inhibited the antiseizure activity of L-AP4, whilst MPPG (40 nmol) reduced both the ...Continue Reading

Citations

Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·J LevensonA Eskin
Jan 5, 2001·Expert Opinion on Investigational Drugs·M C Walker, J W Sander
Jan 23, 2003·Synapse·T KralD Dietrich
Aug 11, 2000·Journal of Neurochemistry·J Cartmell, D D Schoepp
Dec 18, 2001·The Journal of Biological Chemistry·Erica RosemondDavid R Hampson
May 21, 2004·Journal of Neurophysiology·Kristopher J BoughRaymond J Dingledine
May 13, 1999·Journal of Neurophysiology·N B KeeleP Shinnick-Gallagher
Aug 29, 2001·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·V BrunoF Nicoletti
Jan 15, 2002·Nature Neuroscience·Jonathan LevensonArnold Eskin
Dec 2, 2020·Pharmaceutics·Manuela Gernert, Malte Feja
Jun 22, 2006·Epilepsy Research·Georgia M Alexander, Dwayne W Godwin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.